| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REYATAZ | 021567 | 001 | NDA | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 2003/06/20 | 2003/06/20 | BRISTOL MYERS SQUIBB | Discontinued |
| REYATAZ | 021567 | 002 | NDA | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 2003/06/20 | 2003/06/20 | BRISTOL MYERS SQUIBB | Discontinued |
| REYATAZ | 021567 | 003 | NDA | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | Yes | No | 2003/06/20 | 2003/06/20 | BRISTOL MYERS SQUIBB | Prescription |
| REYATAZ | 021567 | 004 | NDA | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | Yes | Yes | 2003/06/20 | 2006/10/16 | BRISTOL MYERS SQUIBB | Prescription |
| REYATAZ | 206352 | 001 | NDA | ATAZANAVIR SULFATE | POWDER;ORAL | EQ 50MG BASE/PACKET | Yes | Yes | 2014/06/02 | 2014/06/02 | BRISTOL MYERS SQUIBB | Prescription |